Morphological lymphocytic reaction, patient prognosis and PD‐1 expression after surgical resection for oesophageal cancer

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

(2019) Timothy F. Cloughesy et al.   NATURE MEDICINE

Multicentre factorial randomized clinical trial of perioperative immunonutrition versus standard nutrition for patients undergoing surgical resection of oesophageal cancer

(2018) L. A. Mudge et al.   BRITISH JOURNAL OF SURGERY

Prognostic Role of Tumor-Infiltrating Lymphocytes in Esophagus Cancer: a Meta-Analysis

(2018) Xiao Zheng et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Safety and Antitumor Activity of the Anti–Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma

(2018) Toshihiko Doi et al.   JOURNAL OF CLINICAL ONCOLOGY

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

(2018) Patrick M. Forde et al.   NEW ENGLAND JOURNAL OF MEDICINE

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016

(2018) et al.   JAMA Oncology

CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer

(2018) Yelena Y. Janjigian et al.   JOURNAL OF CLINICAL ONCOLOGY

Predictive biomarkers of response for immune checkpoint inhibitors in non–small-cell lung cancer

(2018) Arsela Prelaj et al.   EUROPEAN JOURNAL OF CANCER

Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial

(2017) Toshihiro Kudo et al.   LANCET ONCOLOGY

Monitoring immune-checkpoint blockade: response evaluation and biomarker development

(2017) Mizuki Nishino et al.   Nature Reviews Clinical Oncology

The Dynamic and Transient Immune Microenvironment in Locally Advanced Esophageal Adenocarcinoma Post Chemoradiation

(2017) Ronan J. Kelly et al.   ANNALS OF SURGERY

Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma

(2016) Sam C. Wang et al.   ANNALS OF SURGERY

New Strategies in Esophageal Carcinoma: Translational Insights from Signaling Pathways and Immune Checkpoints

(2016) V. E. Wang et al.   CLINICAL CANCER RESEARCH

Basis for molecular diagnostics and immunotherapy for esophageal cancer

(2016) Joe Abdo et al.   Expert Review of Anticancer Therapy

Predictive biomarkers for checkpoint inhibitor-based immunotherapy

(2016) Geoffrey T Gibney et al.   LANCET ONCOLOGY

CD8+/FOXP3+ ratio and PD-L1 expression associated with survival in pT3N0M0 stage esophageal squamous cell cancer

(2016) Yingming Zhu et al.   Oncotarget

Immune Checkpoint Blockade in Cancer Therapy

(2015) Michael A. Postow et al.   JOURNAL OF CLINICAL ONCOLOGY

High infiltration of tumor-associated macrophages is associated with a poor response to chemotherapy and poor prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer

(2015) Keijiro Sugimura et al.   JOURNAL OF SURGICAL ONCOLOGY

Evaluation of a Tumor Microenvironment-Based Prognostic Score in Primary Operable Colorectal Cancer

(2014) J. H. Park et al.   CLINICAL CANCER RESEARCH

Prognostic importance of tumour-infiltrating memory T cells in oesophageal squamous cell carcinoma

(2012) K. Enomoto et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction

(2010) Thomas W. Rice et al.   ANNALS OF SURGICAL ONCOLOGY

Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype

(2009) S. Ogino et al.   CLINICAL CANCER RESEARCH

Tumour inflammatory infiltrate predicts survival following curative resection for node-negative colorectal cancer

(2009) Campbell S.D. Roxburgh et al.   EUROPEAN JOURNAL OF CANCER

Use of tumour-responsive T cells as cancer treatment

(2009) Mary L Disis et al.   LANCET

Infiltrating regulatory T cell numbers is not a factor to predict patient's survival in oesophageal squamous cell carcinoma

(2008) T Yoshioka et al.   BRITISH JOURNAL OF CANCER